Related Experiment Video
Updated: Jun 22, 2026

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
Published on: December 1, 2011
Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype
R Nedellec1, M Coetzer, N Shimizu
1Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
HIV-1 subtypes show distinct coreceptor usage. Subtype B uses CCR3, while subtypes A and C utilize FPRL1, impacting viral entry and potential drug resistance.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) entry relies on CD4 and coreceptors (CoRs), typically CCR5.
- While CXCR4 is a known alternative CoR, the roles of other CoRs across HIV-1 subtypes are not fully understood.
Purpose of the Study:
- To investigate differential HIV-1 entry into target cells mediated by various alternative coreceptors across major HIV-1 subtypes.
- To determine correlations between CCR5 entry efficiency and alternative CoR usage, and if these correlations vary by subtype.
Main Methods:
- Analysis of HIV-1 envelope (Env) proteins from 66 individuals across major subtypes.
- Assessing virus entry into NP-2 cell lines expressing known alternative CoRs.
- Linear regression analysis to correlate CCR5 entry with alternative CoR utilization by subtype.
Main Results:
- Subtype B Env demonstrated efficient entry via CCR3, strongly correlated with CCR5 efficiency.
- Subtypes A and C Env utilized FPRL1 more effectively than CCR3, with FPRL1 use correlated to CCR5 entry.
- Subtype D Env showed limited efficiency with CCR3 and FPRL1, indicating a unique CoR usage pattern.
Conclusions:
- HIV-1 subtypes exhibit distinct selective pressures influencing Env-mediated entry.
- CCR3 may act as a surrogate CoR for subtype B, while FPRL1 serves this role for subtypes A and C.
- Understanding these alternative entry pathways is crucial for predicting resistance to CCR5 inhibitors and developing new therapeutics.
More Related Videos
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
10:50Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010
Related Concept Videos
Retroviruses
Retrovirus Life Cycles
Viral Recombination
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Inhibitors Of Virion Release
Viruses with RNA Genomes